Related Experiment Videos
Hypertension in older people: part 2
1Heart Disease Prevention Program, University of California, Irvine, 92697, USA. ssfranklinmd@earthlink.net
Journal of Clinical Hypertension (Greenwich, Conn.)
|July 20, 2006
Summary
Treating isolated systolic hypertension (ISH) in older adults reduces cardiovascular events. Effective control, often requiring multiple medications, is crucial for managing arterial stiffness and improving health outcomes in the elderly.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Isolated systolic hypertension (ISH) is prevalent in the elderly, characterized by elevated systolic blood pressure (>or=140 mm Hg) and normal diastolic blood pressure (<90 mm Hg).
- ISH in older adults is primarily linked to increased large artery stiffness, making it challenging to manage compared to younger individuals with diastolic hypertension.
- Despite evidence of reduced cardiovascular events and improved longevity, ISH treatment in the elderly remains suboptimal, with a low percentage achieving target blood pressure goals.
Purpose of the Study:
- To emphasize the critical importance of controlling isolated systolic hypertension (ISH) in the elderly due to the increased risk of vascular events.
- To highlight the specific challenges in managing ISH in older populations, particularly those related to arterial stiffness.
- To advocate for appropriate lifestyle and pharmacologic interventions for ISH management in elderly individuals, including those with diabetes or chronic kidney disease.
Main Methods:
- Review of existing evidence on the pharmacologic treatment of isolated systolic hypertension (ISH) in the elderly.
- Analysis of the relationship between arterial stiffness and hypertension control in different age groups.
- Assessment of current treatment patterns and goal achievement rates for ISH in older patients.
Main Results:
- Pharmacologic treatment of ISH significantly reduces cardiovascular events and extends longevity in the elderly, with proven benefits for stroke and heart failure reduction in the very old.
- ISH in the elderly, driven by arterial stiffness, is more difficult to control than diastolic hypertension in younger individuals.
- Achieving target systolic blood pressure levels in older adults frequently necessitates polypharmacy, including diuretics and agents targeting arterial stiffness.
Conclusions:
- Controlling isolated systolic hypertension (ISH) is essential for reducing cardiovascular risk and improving outcomes in the elderly.
- Effective management of ISH in older adults requires addressing underlying arterial stiffness and often involves a combination of lifestyle modifications and multiple antihypertensive medications.
- Increased awareness and improved treatment strategies are needed to ensure more elderly patients with ISH achieve their blood pressure goals.
Related Concept Videos
Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...